ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,575, issued on June 30, was assigned to HANGZHOU APELOA MEDICINE RESEARCH INSTITUTE Co. LTD. (Zhejiang, China) and APELOA PHARMACEUTICAL Co. LTD. (Zhejiang, China).
"N-(benzoyl)-phenylalanine compound, pharmaceutical composition containing same, and use thereof" was invented by Weiqiang Zhan (Zhejiang, China), Zhanguo Wang (Zhejiang, China), Fanglei Chen (Zhejiang, China), Fengming Yang (Zhejiang, China), Jianbo Wu (Zhejiang, China) and Fangmeng Zhu (Zhejiang, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of pharmaceutical chemistry, and relates to an N-(benzoyl)-phenylalanine compound used as an Alp...